X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ALKEM LABORATORIES - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS ALKEM LABORATORIES NOVARTIS/
ALKEM LABORATORIES
 
P/E (TTM) x 342.8 - - View Chart
P/BV x 16.9 6.1 275.2% View Chart
Dividend Yield % 1.7 0.7 241.9%  

Financials

 NOVARTIS   ALKEM LABORATORIES
EQUITY SHARE DATA
    NOVARTIS
Mar-16
ALKEM LABORATORIES
Mar-16
NOVARTIS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs9821,589 61.8%   
Low Rs5561,232 45.1%   
Sales per share (Unadj.) Rs252.9417.5 60.6%  
Earnings per share (Unadj.) Rs62.156.3 110.4%  
Cash flow per share (Unadj.) Rs63.364.7 97.8%  
Dividends per share (Unadj.) Rs10.0012.70 78.7%  
Dividend yield (eoy) %1.30.9 144.4%  
Book value per share (Unadj.) Rs363.6292.9 124.1%  
Shares outstanding (eoy) m31.96119.57 26.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.03.4 90.0%   
Avg P/E ratio x12.425.1 49.4%  
P/CF ratio (eoy) x12.221.8 55.7%  
Price / Book Value ratio x2.14.8 43.9%  
Dividend payout %16.122.6 71.3%   
Avg Mkt Cap Rs m24,580168,653 14.6%   
No. of employees `0000.8NA-   
Total wages/salary Rs m1,8019,171 19.6%   
Avg. sales/employee Rs Th10,748.9NM-  
Avg. wages/employee Rs Th2,395.2NM-  
Avg. net profit/employee Rs Th2,641.1NM-  
INCOME DATA
Net Sales Rs m8,08349,915 16.2%  
Other income Rs m8291,645 50.4%   
Total revenues Rs m8,91351,561 17.3%   
Gross profit Rs m2348,482 2.8%  
Depreciation Rs m371,006 3.6%   
Interest Rs m2671 0.3%   
Profit before tax Rs m1,0258,451 12.1%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m7521,606 46.8%   
Profit after tax Rs m1,9866,731 29.5%  
Gross profit margin %2.917.0 17.1%  
Effective tax rate %73.419.0 386.0%   
Net profit margin %24.613.5 182.2%  
BALANCE SHEET DATA
Current assets Rs m12,67827,062 46.8%   
Current liabilities Rs m2,43315,324 15.9%   
Net working cap to sales %126.723.5 539.0%  
Current ratio x5.21.8 295.1%  
Inventory Days Days3367 49.2%  
Debtors Days Days2241 54.5%  
Net fixed assets Rs m6912,610 0.5%   
Share capital Rs m160239 66.8%   
"Free" reserves Rs m11,46034,490 33.2%   
Net worth Rs m11,62135,027 33.2%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m14,40054,387 26.5%  
Interest coverage x570.513.6 4,194.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.9 61.2%   
Return on assets %13.813.6 101.4%  
Return on equity %17.119.2 88.9%  
Return on capital %23.624.9 94.8%  
Exports to sales %0.712.9 5.8%   
Imports to sales %18.63.1 602.4%   
Exports (fob) Rs m606,461 0.9%   
Imports (cif) Rs m1,5031,540 97.6%   
Fx inflow Rs m1866,563 2.8%   
Fx outflow Rs m1,8213,012 60.5%   
Net fx Rs m-1,6353,552 -46.0%   
CASH FLOW
From Operations Rs m2,5317,259 34.9%  
From Investments Rs m-8,2701,864 -443.6%  
From Financial Activity Rs m-386-9,273 4.2%  
Net Cashflow Rs m-6,125-150 4,083.0%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 33.1 6.0%  
FIIs % 1.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 0.0 -  
Shareholders   41,647 68,381 60.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  BIOCON LTD  J.B.CHEMICALS  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 21, 2017 02:09 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS